P2.17-10 Daily Low–Dose Cisplatin and High Dose Radiotherapy for Elderly Patients With Stage III NSCLC Is Well Tolerated.

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1536

Related search